A
Street view: Consensus is BUY with an implied target of INR 6,660.
Bulls: Strong operational performance in diagnostics and pharmacy segments; ramp-up in new hospitals to drive growth.
Bears: Potential margin pressure from increased competition; execution risks in new hospital launches.